Hajime Ueda
Overview
Explore the profile of Hajime Ueda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miwa T, Tsuruoka M, Ueda H, Abe T, Inada H, Yukawa-Muto Y, et al.
J Gastroenterol
. 2025 Mar;
PMID: 40053108
Background: Covert hepatic encephalopathy (CHE) leads to devastating outcomes in patients with cirrhosis. This study aims to elucidate the current management and future perspectives of CHE in Japan. Methods: A...
2.
Ueda H, Honda A, Miyazaki T, Morishita Y, Hirayama T, Iwamoto J, et al.
Hepatol Commun
. 2024 Dec;
9(1).
PMID: 39670881
Background: Wild-type (WT) mice fed a conventional high-fat/high-sucrose diet (HFHSD) rarely develop metabolic dysfunction-associated steatohepatitis (MASH) with HCC. Because mouse bile acid (BA) is highly hydrophilic, we hypothesized that making...
3.
Miyazaki T, Ueda H, Ikegami T, Honda A
Metabolites
. 2023 Jul;
13(7).
PMID: 37512531
Taurine, the end product in the sulfur-containing amino acid pathway, is conjugated with bile acids (BAs) in the liver. The rate-limiting enzymes in both taurine synthesis and BA conjugation may...
4.
Monma T, Iwamoto J, Ueda H, Tamamushi M, Kakizaki F, Konishi N, et al.
World J Clin Cases
. 2022 Dec;
10(34):12484-12493.
PMID: 36579096
Dysbiosis in the intestinal microflora can affect the gut production of microbial metabolites, and toxic substances can disrupt the barrier function of the intestinal wall, leading to the development of...
5.
Matsumoto A, Ueda H, Ogawa A, Oshima C, Irie K, Liang N
Sci Rep
. 2022 Dec;
12(1):22385.
PMID: 36572719
Whether attentional focus modulates the corticospinal excitability of the lower limb muscles in anticipatory postural adjustments (APAs) when performing a ballistic movement of the upper limb remains unclear. The present...
6.
Ueda H, Honda A, Miyazaki T, Morishita Y, Hirayama T, Iwamoto J, et al.
PLoS One
. 2022 Jul;
17(7):e0271308.
PMID: 35819971
Cyp2a12-/-Cyp2c70-/- double knockout (DKO) mice have a human-like hydrophobic bile acid (BA) composition and show reduced fertility and liver injury. Ursodeoxycholic acid (UDCA) is a hydrophilic and cytoprotective BA used...
7.
Monma T, Iwamoto J, Honda A, Ueda H, Kakizaki F, Yara S, et al.
Metabolites
. 2022 Apr;
12(4).
PMID: 35448518
Since intestinal secondary bile acids (BAs) prevent Clostridium difficile infection (CDI), the serum BA profile may be a convenient biomarker for CDI susceptibility in human subjects. To verify this hypothesis,...
8.
Matsumoto A, Liang N, Ueda H, Irie K
Front Hum Neurosci
. 2021 Nov;
15:703377.
PMID: 34776899
To investigate whether the changes in the corticospinal excitability contribute to the anticipatory postural adjustments (APAs) in the lower limb muscles when performing the ballistic upper limb movement of the...
9.
Iwamoto J, Honda A, Miyazaki T, Monma T, Ueda H, Morishita Y, et al.
Hepatol Commun
. 2021 Sep;
5(12):2052-2067.
PMID: 34558859
Western-style high-fat/high-sucrose diet (HFHSD) changes gut microbiota and bile acid (BA) profiles. Because gut microbiota and BAs could influence each other, the mechanism of changes in both by HFHSD is...
10.
Iwamoto J, Murakami M, Monma T, Ueda H, Tamamushi M, Konishi N, et al.
J Clin Biochem Nutr
. 2020 Apr;
66(2):158-162.
PMID: 32231413
Non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA) are the most common causes of drug-induced gastroduodenal ulcer and We investigated preventive treatment with use of concomitant anti-ulcer drugs and the...